BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 18360697)

  • 1. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
    Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M; Masaki T; Seike M; Yoshimatsu H
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease].
    Yang ZX; Sun H; Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):823-6. PubMed ID: 19032865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways.
    Boonsong T; Norton L; Chokkalingam K; Jewell K; Macdonald I; Bennett A; Tsintzas K
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1310-1. PubMed ID: 17956338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways.
    Park KG; Min AK; Koh EH; Kim HS; Kim MO; Park HS; Kim YD; Yoon TS; Jang BK; Hwang JS; Kim JB; Choi HS; Park JY; Lee IK; Lee KU
    Hepatology; 2008 Nov; 48(5):1477-86. PubMed ID: 18972440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
    J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin immuno-neutralization in chicken: effects on insulin signaling and gene expression in liver and muscle.
    Dupont J; Tesseraud S; Derouet M; Collin A; Rideau N; Crochet S; Godet E; Cailleau-Audouin E; Métayer-Coustard S; Duclos MJ; Gespach C; Porter TE; Cogburn LA; Simon J
    J Endocrinol; 2008 Jun; 197(3):531-42. PubMed ID: 18492818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs.
    Dif N; Euthine V; Gonnet E; Laville M; Vidal H; Lefai E
    Biochem J; 2006 Nov; 400(1):179-88. PubMed ID: 16831124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice.
    Yang J; Maika S; Craddock L; King JA; Liu ZM
    Biochem Biophys Res Commun; 2008 May; 370(2):248-53. PubMed ID: 18381066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
    AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
    Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin regulation of glucokinase gene expression: evidence against a role for sterol regulatory element binding protein 1 in primary hepatocytes.
    Gregori C; Guillet-Deniau I; Girard J; Decaux JF; Pichard AL
    FEBS Lett; 2006 Jan; 580(2):410-4. PubMed ID: 16380121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.
    Liu JF; Ma Y; Wang Y; Du ZY; Shen JK; Peng HL
    Phytother Res; 2011 Apr; 25(4):588-96. PubMed ID: 20925133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.